Why This Week Is Historic for Cannabis Policy in the US

Federal hearings began this week on the constitutionality of cannabis’ continuing Schedule I classification in Sacramento, California.

There are many reasons why these historic hearings are a very big deal. This is the first time hearings are taking place that question whether federal law should classify cannabis as one of the nation’s most dangerous drugs with no medicinal value.

Many patients living in Colorado where cannabis oil is legal, are benefitting. There are hundreds of families whose children have severe epilepsy and their seizures are now under control.

Members of Congress initially categorized cannabis as a Schedule I substance, the most restrictive classification available, in 1970. Under this categorization, the plant is defined as possessing “a high potential for abuse, … no currently accepted medical use in treatment in the United States, … [and lacking] accepted safety for … use … under medical supervision.”

One of the expert witnesses is Dr. Carl Hart, Associate Professor of Psychology in the Department of Psychiatry and Psychology at Columbia University in New York City, who declared, “[I]t is my considered opinion that including marijuana in Schedule I of the Controlled Substances Act is counter to all the scientific evidence in a society that uses and values empirical evidence.”

“After two decades of intense scientific inquiry in this area, it has become apparent the current scheduling of cannabis has no footing in the realities of science and neurobiology.”

Modern research suggests that cannabis is a valuable aid in the treatment of a wide range of clinical applications. These include pain relief — particularly of neuropathic pain (pain from nerve damage) — nausea, spasticity, glaucoma, and movement disorders. Marijuana is also a powerful appetite stimulant, specifically for patients suffering from HIV, the AIDS wasting syndrome, or dementia. Emerging research suggests that marijuana’s medicinal properties may protect the body against some types of malignant tumors and are neuroprotective.

Currently, more than 60 U.S. and international health organizations support granting patients immediate legal access to medicinal marijuana under a physician’s supervision.

(READ more from the National Organization for the Reform of Marijuana Laws)

Photo from Phil Roede (CC license)